Governor Noem says she’s been asking the president and other members of his administration to allow South Dakota to launch a statewide trial. This weekend, the state received a shipment of the drug.
Noem says a trial usually needs about 2,000 participants.
“We can treat up to 100,000 people with the amount of doses we have in the state of South Dakota,” Noem says.
All three of the state’s major healthcare systems are on board. Dr. Allison Suttle is the chief medical officer for Sanford Health in Sioux Falls. She says researchers are learning hydroxychloroquine may prevent viruses from entering a person’s cells.
Dr. Suttle says there are multiple trials ongoing. There are in-patient and out-patient trials for patients who test positive for COVID-19, and there’s a clinical trial for high risk people who’ve been exposed to the virus.
South Dakota is launching the first statewide trial of a possible treatment for COVID-19 in the nation. The trial drug typically treats malaria, lupus, and rheumatoid arthritis.#CovidSDhttps://t.co/LWgUYqv7hg
— SDPB News (@SDPBNews) April 13, 2020
Article submitted by, A Non Ymous.
